Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04692506
Status:
COMPLETED
Last Update Posted:
2021-06-18
First Post:
2020-12-16
Brief Title:
Study Evaluating the Safety and Tolerability
Sponsor:
BioGaia AB
Organization:
BioGaia AB
Study Overview
Official Title:
A Double-blind Randomised Placebo-controlled Parallel-group Study Evaluating the Safety and Tolerability of Bifidobacterium Longum DSM 32947 Administered to Healthy Volunteers for 28 Days
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The rationale for the current study is to initially evaluate the safety and tolerability of B longum strain in healthy volunteers
Detailed Description:
The design of the study is based on the aim to study safety and tolerability of B longum in a limited number of healthy volunteers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None